SCPH
scPharmaceuticals
SCPH
SCPH
Delisted
SCPH was delisted on the 6th of October, 2025.
35 hedge funds and large institutions have $47.3M invested in scPharmaceuticals in 2018 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 14 increasing their positions, 7 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
75% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 8
Holders
35
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$376K | |
| 2 | +$196K | |
| 3 | +$123K | |
| 4 |
State Street
Boston,
Massachusetts
|
+$97.8K |
| 5 |
Bank of New York Mellon
New York
|
+$30.9K |
Top Sellers
| 1 | -$306K | |
| 2 | -$173K | |
| 3 | -$131K | |
| 4 |
Millennium Management
New York
|
-$109K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$95K |